I demonstrating both qualitative and quantitative effects of recombinant hematopoietic growth factors on committed progenitor cells.'.3 Hematopoietic growth factors also effect the formation of colonies derived from more primative progenitor cells in vitro, namely the multi-colony-forming cell (CFC-multi),4.' high profiferative potential-CFC (HPP-CFC),6-'' and the blast colony progenitor These three assays share in common dependence on interleukin-3 (IL-3) for formation, and the numbers of colonies increased (CFC-multi and HPP-CFC), or the time required for colony formation decreased (blast colony progenitor) by the addition of other factors to the culture medium. Among the most potent combinations of factors that produce these effects are IL-3 and IL-la (all three assay^)^*'^^' IL-3 and IL-6, and IL-3 and granulocyte-colony-stimulating factor (G-CSF; HPP-CFC and blast colony assays ~n l y ) . '~, '~,~~ There are two in vivo assays for primitive hematopoietic stem cells. The colony-forming unit-spleenl4 (CFU-S,,) assay measures the number of progenitor cells capable of forming large colonies on the spleens of irradiated mice 14 days posttran~plantation.'~ These colonies contain varying numbers of mature cells of most myeloid lineages, and they have extensive self renewal potential. The competitive repopulation assay measures the relative contribution of repopulating stem cells to the long-term reconstitution of hematopoiesis in irradiated or genetically anemic mice.M We have previously shown that IL-3 is required for CFU-S to survive in liquid suspension culture. In addition, the combination of IL-3 and IL-6 increases the number of CFU-S in these cultures fivefold to 10-fold. This increase was accompanied by an increase in the number of actively cycling CFU-S.'l Using the competitive repopulation assay, we have shown that IL-3 is required for the survival of long-term repopulating stem cells in liquid suspension cultures, and that long-term repopulating activity is enhanced by the combination of IL-3 and IL-6. This increased repopulating ability was accompanied by an increased susceptibility to recombinant retrovirus integration, which depends on cells being in cycle. 'l In this report we describe the effects of 10 different hematopoietic growth factors alone and in combination on both CFU-S and on long-term repopulating stem cell survival in liquid suspension culture. IL-3, G-CSF, and IL-4 alone can support CFU-S in liquid suspension culture, and CFU-S survival is increased synergistically by combining IL-3 with either G-CSF, IL-la, or granulocyte-macrophage CSF (GM-CSF), and by the combination of IL-4 and IL-6. Only IL-3 or IL-4 alone can support long-term repopulating ability in liquid suspension culture, and repopulating ability is increased by the combination of either IL-6 or G-CSF with IL-3.
MATERIALS AND METHODS
Mice. All mice were purchased from The Jackson Laboratory (Bar Harbor ME). For CFU-S experiments 1 through 5, inbred DBN2J mice were used as donors, and B6D2F, hybrid mice were used as recipients. In the remainder of the CFU-S experiments, inbred C57BW6J mice were used as donors, and WBB6Fl hybrid mice were used as recipients. In the competitive repopulation assays, the inbred donors were: C57BLl6J ( 
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BM cells were cultured in 10 mL medium for 6 days at 37°C in 5% C 0 2 in air. The cells were cultured in 10-cm Sarstedt petri plates to prevent adherence of cells. The medium was composed of Dulbec-CO'S modified Eagle medium (DMEM; GIBCO, Grand Island, NY) with 15% fetal calf serum (FCS; Hyclone), 4 mmol/L L-glutamine, 50 mg/mL penicillin, 50 U/mL streptomycin, and the appropriate growth factors. Following culture, the BM cells were collected washed, and the viable cell number determined.
Murine IL-3, IL-6, IL-4, IL-7, and GM-CSF, as well as human IL-la and leukemia inhibitory factodhuman interleukin for DA cells (LIFWILDA) were produced by transfecting expression plasmids containing the appropriate gene into COS cells and harvesting the supernatant 48 hours later. Human G-CSF was produced by stably transfected CHO cells. Recombinant human macrophage-CSF (M-CSF) was purified from Escherichia coli. The activities of each growth factor were determined using the appropriate bioassay. IL-3, IL-6, and M-CSF were used at 100 U/mL. The concentration of all other growth factors was adjusted to be 20-fold higher than the concentration required to half maximally stimulate the indicator cell line. In CFU-S experiment 9, murine IL-7, human IL-la, and human LIFWILDA were used at 200-fold the half maximum concentration. In all experiments, medium conditioned by untransfected COS cells was used as a control. No CFU-S survived in medium containing 10% CHO cell-conditioned medium.
CFW-S survival assay. Cells were injected into irradiated (900 R) recipient animals as described previo~sly.'~ Spleens were harvested 14 days after injection of cells and fixed in Telly's futative before determining the number of visible CFU-S. The number of visible CFU-S on a spleen was divided by the total number of cells Neutralizing monoclonal antibodies (MoAbs) to murine IL-3 (8F823; a kind gift from John Abrams and Donna Rennick, DNAX Corp, San Francisco, CA) and murine IL-4 (llBllz4; Texstar Monoclonals, Dallas, TX) and rabbit antibody to human G-CSF (produced at Oenetics Institute, Cambridge, MA) were added to a final concentration of 6 mgimL, 10 mg/mL, and 5 mg/mL, respectively, to medium containing the indicated growth factors. The specificity of the 8F8 and l l B l l MoAbs against IL-3 and IL-4, respectively, is described in the original references. The specificity of the anti-G-CSF antibody was determined at GeQetics Institute. 5-FU-treated BM cells from C57BL/6J donors were cultured in this media as above and injected into WBB6F1 recipients. Calculation of CFU-S numbers was as described above.
The competitive repopulation assay was performed as described by Harrison." A total of at least 1.2 x 10'viable C57BLi6J (single hemoglobin) cells cultured in the indicated growth factor were mixed with an equal number of viable HW80 (diffuse hemoglobin) cells cultured ip murine IL-3. These cells were injected into five or more WBB6Fl-W/W recipients such that each animal received at least 4 x lo6 viable cells. At intervals following transplantation, peripheral blood was obtained from these recipients and the percentage of single and diffuse hemoglobin determined by the method of Whitney.2s The Pep-3 phenotype was determined by the method of Eppig and Eicher.z6
Antibodies.
Competitive repopulation assays. 
RESULTS
into lethally irradiated syngeneic mice for enumeration of day 14 CFU-S. TWO different donorlrecipient systems were used-In all cases, BM from 5-FU-treated DBA/D dOnors injected into B6D2F1 recipients generated approximately fivefold more CFU-S than BM from 5-FU-treated C57BL/6J donors injected into WBB6F, recipients (compare day of harvest results in Tables 1 and 2 ). This result may be related Effects of single growth factors on CFU-S survival in liquid suspension culture. The effects of growth factors on primitive hematopoietic progenitor cells was examined using a CFU-S survival assay. In this assay, BM cells from 5-FUtreated donor mice are maintained in liquid suspension culture for 6 days. Following culture the cells are injected to the increased resistance of DBNW marrow to 5-FUZ7 and/or decreased numbers of pre-multi-CFC in C57BLi6J marrow.' Nine separate experiments are shown in Tables 1 apd 2 . BM cells from either strain cultured for 6 days in medium supplemented with supernatant form untransfected COS cells generated less than 1 CFu-S/107 cells injected. Similarly, BM cells cultured in medium supplemented with COS supernatants containing either IL-la, IL-6, IL-7, or GM-CSF, or highly purified preparations of M-CSF or LIF/ HILDA generated less than 1 CFU-S/106 (Tables 1 and 2) .
As shown previously, CFU-S were present in BM cells cultured in medium containing IL-3." CFU-S also survived in medium containing either G-CSF or IL-4. More CFU-S were generated from marrow cultured in the presence of IL-3 than from marrow cultured with G-CSF, which in turn generated more CFU-S than marrow cultured in IL-4.
To determine whether these effects were directly related to the introduction of IL-3, G-CSF, or IL-4, BM cells from C57BLi6J donors were cultured in the presence of each growth factor and specific neutralizing antibodies to IL-3, G-CSF, or IL-4. CFU-S survival in the presence of IL-3 was almost completely eliminated by the addition of the anti-IL-3 antibody (P < .OOl), but was unaffected by anti-G-CSF (P = .26), or anti-IL-4 (P = .29) antibodies (Fig 1,  columns 2 through 4, respectively) . Likewise, CFU-S survival in the presence of G-CSF was almost completely eliminated by the addition of the anti-G-CSF antibody (P < .001), but was unaffected by anti-IL-3 (P = .84), or anti-IL-4 (P = .22) antibodies (Fig 1, columns 7, 6 , and 8, respectively). CFU-S survival in the presence of IL-4 was almost completely eliminated by the addition of the anti-IL-4 antibody (P < .001). However, CFU-S survival was also reduced approximately 50% by the addition of anti-IL-3 (P = .003), and over 75% (P = .001) by the addition of anti-G-CSF antibodies, respectively (Fig 1, columns 12 , 10, and 11, respectively). This experiment was performed three times with similar results.
Effects of combinations ofgrowth factors on CFU-S survival in liquid suspension culture. CFU-S survival was measured in the presence of each growth factor plus IL-3. The combination of IL-3 and either IL-7, M-CSF, or LIF/ HILDA generated approximately the same number of CFU-S as BM cultured in IL-3 alone (Tables 1 and 2) . As shown previously, BM cells cultured in the combination of IL-3 and IL-6 generated over fivefold more CFU-S than BM cultured in IL-3 alonez1 (Tables 1 and 2 ). Similarly, BM cells cultured in the combination of G-CSF and IL-3 generated over fivefold more CFU-S than BM cultured in either G-CSF or IL-3 alone (Table 1) . BM cells cultured in the presence of IL-3 and IL-la, and IL-3 and GM-CSF contained increased numbers of CFU-S as well. BM cells cultured in the presence of IL-3 and IL-4 generated a total number of CFU-S that was approximately equal to the sum of those generated by IL-3 and IL-4 alone (Tables 1 and 2) .
CFU-S survival was measured in the presence of several growth factors plus IL-6. BM cells cultured in the presence of the combination of G-CSF and IL-6 generated approximately the same number of CFU-S as G-CSF alone (Tables  1 and 2 ). BM cells cultured in the presence of the combination of IL-4 and IL-6 generated over 10-fold more CFU-S than €$M cultured in IL-4 alone (Tables 1 and 2) . Finally, BM cells cultured in the presence of IL-3, G-CSF, and IL-6 generated over fivefold more CFU-S than the sum of the CFU-S generated by these factors alone (Tables 1  and 2) .
A secondary CFU-S assay was performed to demonstrate the self-renewal potential of CFU-S derived from BM cells cultured in liquid suspension culture. Individual 14-day CFU-S derived from BM cells cultured for 6 days in the presence of IL-3 or the combination of IL-3 plus IL-6 were dissected and injected into secondary recipients. These cells gave rise to secondary 14-day CFU-S (data not shown).
Macrophage inflammatory protein-la (MIP-la) has been shown to inhibit CFU-S proliferation in primary cultures of BM cells.z8 BM cells cultured for 6 days in the presence of MIP-la contained a low level of CFU-S relative to cells cultured in IL-3 or IL-3 and IL-6 ( Table 3 ). The number of CFU-S derived from cells cultured in the combination of MIP-la and IL-3 was nearly identical to that of cells cultured in IL-3 alone. In contrast, the number of CFU-S derived from cells cultured in the combination of MIP-la, IL-3, and IL-6 was threefold less than that of cells cultured in IL-3 and IL-6 (P < .001; Table 3 ). We have previously shown that the number of CFU-S decreases sharply during the first 2 days of culture in either IL-3 or IL-3 and IL-6. This decrease is followed by an increase in CFU-S number in cultures containing IL-3 and IL-6 between day 2 and day 
6.2' This recovery was inhibited by the addition of MIP-la
to these cultures (P < .001; Table 3 ).
Effects of growth factors on long-[erm repopulating stem cell survival in liquid suspension culture. The effects of growth factors on long-term repopulating stem cells was examined using a competitive repopulation assay. In this assay, BM cells from histocompatible, but genetically distinguishable mice are mixed and allowed to reconstitute syngeneic genetically anemic recipients. The repopulating ability of the long-term repopulating stem cells is measured by the relative amounts of the genetically distinguishable markers in the reconstituted recipients.m BM cells from 5-FUtreated HW80 mice (congenic with C57BL/6J, "diffuse" hemoglobin) were maintained in liquid suspension culture for 6 days in the presence of IL-3. BM cells from 5-FUtreated C57BL/6J mice ("single" hemoglobin) were maintained in liquid suspension culture for 6 days in the presence of various growth factor combinations. Following culture, equal numbers of HW80 cells and C57BW6J cells were injected into W/W recipients. Peripheral blood was analyzed at various times posttransplantation (up to 120 days) for the relative amounts of diffuse and single hemoglobin.
As shown previously, HW80 and C57BL/6J cells cultured in IL-3 repopulated recipient mice equivalently." Analysis of the Pep-3 isozyme phenotype of these animals demonstrated that they were homozygous for the "a" allele of the donor strains, not heterozygous "a/b" like the recipient animals, indicating complete reconstitution.
At 35 days posttransplantation, BM cells cultured in G-CSF alone contributed significantly fewer circulating erythroid cells relative to cells cultured in IL-3 (P < .001; Table 4 ). BM cells cultured in the presence of IL-6 and G-CSF or IL-3 + IL-6 + G-CSF contributed equivalent amounts of circulating erythroid cells as BM cells cultured The percentage of single and diffuse hemoglobins was rounded to *P < .001 with respect to IL-311L-3. t P < .01 with respect to IL-3/IL-3. *P < .05 with respect to IL-3AL-3. §P > .05 with respect to IL-3/IL-3.
the nearest whole number.
in IL-3. BM cells cultured in the presence of IL-4 alone (P < .OS), or the combinations of IL-3 and G-CSF (P < .Ol), IL-3 and IL-6 (P < .Ol), or IL-3 and G-CSF (P < .01)
contributed significantly more circulating erythroid cells relative to cells cultured in IL-3 (Table 4) . By 120 days posttransplantation, BM cells cultured in the presence of G-CSF alone (P < .001), as well as the combinations of G-CSF and IL-6 (P < .001), IL-4 and IL-6 (P < .Ol), or IL-3 + G-CSF + IL-6 (P < .01) all contributed significantly fewer circulating erythroid cells relative to BM cells cultured in IL-3 ( Table 4) Table 4) . Separate experiments demonstrated results similar to those presented in Table 4 . RBCs appearing at the early stages of reconstitution are derived from CFU-S and later stage progenitors. BM cells cultured in some growth factor combinations (IG4 and IL-6, G-CSF and IL-6, and IL-3 + G-CSF + IL-6) contribute more or equal numbers of circulating erythroid cells than BM cells cultured in IL-3 at 35 days posttransplantation, but at 120 days posttransplantation contribute significantly fewer red blood cells (RBCs) than cells cultured in IL-3. One explanation for these results is that during the early phases of reconstitution, new circulating RBCs are derived from CFU-S and other progenitor cells that lack long-term repopulating ability, rather than from a longterm repopulating stem cell. To test this hypothesis, BM from C57Bw6J mice (single hemoglobin) treated with 150 mglkg 5-FU was compared with BM from untreated HW80 mice (diffuse hemoglobin). 5-FU treatment is toxic to cycling progenitor cells, including CFU-S, while sparing the long-term repopulating stem cells that are rarely in cell At early time points during reconstitution, there was relatively little contribution from the CFU-S and progenitor-depleted 5-FU-treated cells, The nadir was reached at 35 days posttransplantation. From this point, the contribution from the 5-FU-treated BM steadily increased, reaching a plateau of 63% by 120 days (Fig 2, closed  circles) . In contrast, the contribution of cells cultured in IL-3 and IL-6 increased rapidly to a peak at 35 days posttransplant. This increased contribution was maintained throughout the experiment relative to cells cultured in IL-3 alone (Fig 2, closed triangles) . Untreated C57BW6J and HW80 BM contributed equally to the reconstitution of the recipient mice, as did 5-FU-treated marrow from C57BL/6J and HW80 mice (Fig 2, open circles, closed squares,  respectively) . This experiment has been performed twice with identical results.
DISCUSSION
The observed effects of hematopoietic growth factors on CFU-S survival in culture are similar to the effects observed by others on blast cell colony formation13"* and HPP-CFC formation?" As with CFU-S survival, blast cell colony formation is supported by IL-3," G-CSF,I4 or IL-4" alone. Because CFU-S survival in the presence of IL-3 and G-CSF can be specifically blocked with antibodies against IL-3 or G-CSF, respectively, we infer that IL-3 and G-CSF act directly on CFU-S. The combinations of IL-3 and IL-6, IL-3 and G-CSF, IL-3 and IL-la, and IL-3 and GM-CSF increase CFU-S survival in culture. These same combinations have all been reported to decrease the time interval between plating and blast cell colony emergen~e,'~""'' although the effects of the combination of IL-3 and GM-CSF are mild." HPP-CFC colony numbers are increased by culture in many of the growth factor combinations that favor CFU-S survival, including IL-3 and IL-6, IL-3 and GM-CSF, and IL-4 and IL-6. However, HPP-CFC numbers are also increased by culture in the combination of IL-6 and G-CSF, which has no effect on CFU-S survival in our assay.
The decreased time interval between plating and blast cell colony emergence has been proposed to be due to a shortening of the Go period of the blast cell colony progenit~rs.'~.'' We have previously shown that the increase in CFU-S in cultures containing IL-3 and IL-6 is accompanied by both an increase in 3H-thymidine-sensitive cells and an increase in the rate of infection by retroviruses, both indicators of cycling cells.z' In this report we show that the increase in CFU-S number in cells cultured in IL-3 and IL-6 can be blocked by the addition of MIP-la, which inhibits cycling of primitive hematopoietic cells in vivo.2s
The combination of IL-3 and LIF/HILDA has been shown to decrease the time interval between plating and human blast cell colony emergence.'* In addition, high concentrations (1,000 U/mL) of LIF/HILDA have been shown to increase CFU-S number twofold in culture. 30 We observed no significant effects of this growth factor combination on CFU-S survival relative to IL-3 alone, even when the BM cells were cultured in medium containing 200 U/mL LIF/HILDA. The experiments described above were performed using approximately fivefold to 50-fold more LIF/ HILDA than was used in our experiments. It appears that higher doses of LIF/HILDA are required to see effects on CFU-S survival in culture.
The effects of IL-4 in the CFU-S survival assay were inhibited by specific MoAbs to both IL-3 and G-CSF as well as antibodies to IL-4. These results infer that the effect of IL-4 on CFU-S survival is mediated by the production of IL-3 and G-CSF by accessory cells. This finding is in contrast to the results of others who concluded that IL-4 acts directly on blast cell colony progenitors and other primitive progenitor^.'^^'^^^' We predict that IL-4 would have no effect on purified CFU-S,32,33 much as the effects of IL-la on blast cell colony formation are observed only when unfractionated marrow preparations are used."
In general, the effects of growth factors on CFU-S in liquid suspension culture were greater than the effects of the growth factors on long-term repopulating cells. In a competitive repopulation assay, we observed a delayed emergence of circulating RBCs derived from 5-FU-treated BM. Because 5-FU treatment has been shown to reduce the number of CFU-S and later progenitor cells while sparing the repopulating stem ~ells,22,'~ we conclude that serial observations of competitive repopulation assays can distinguish progeny of cells with short-term repopulating ability (CFU-S) from those of long-term repopulating stem cells. We observed that many combinations of growth factors, including the combinations of IL-4 and IL-6, or IL-3 + G-CSF + IL-6 improved CFU-S survival in culture. Consistent with these observations, at 35 days posttransplantation, BM cultured in the combination of IL-4 and IL-6, or IL-3 + G-CSF + IL-6, contributed greater or equivalent numbers of circulating RBCs than BM cultured in IL-3 alone. However, by 120 days, relatively few RBCs were derived from BM cultured in IL-4 and IL-6, or IL-3 + G-CSF + IL-6, indicating a negative effect on long-term repopulating stem cell function. We conclude that certain combinations of growth factors can enhance CFU-S survival in vitro while having a negative effect on repopulating stem cells.
